|
|
||||||||
Departments of 1 Neurology, 4 Biomathematics, and the 2 Brain Research Institute, University of California, Los Angeles School of Medicine, Los Angeles 90095, and 3 Southwest Regional Veterans Administration Epilepsy Center, Neurology Service, Veterans Administration West Los Angeles Medical Center, Los Angeles, California 90073
Brain extraction of 18F-labeled
2-fluoro-2-deoxy-D-glucose (FDG) was significantly higher
in pentylene tetrazole (PTZ)-treated rats (32 ± 4%) than
controls (25 ± 4%). The FDG permeability-surface area product
(PS) was also significantly higher with PTZ treatment (0.36 ± 0.05 ml · min
1 · g
1) than in
controls (0.20 ± 0.06 ml · min
1 · g
1). Cerebral
blood flow rates were also elevated by 50% in seizures. The internal
carotid artery perfusion technique indicated mean [14C]glucose clearance (and extraction) was increased
with PTZ treatment, and seizures increased the PS by
37 ± 16% (P < 0.05) in cortical regions.
Because kinetic analyses suggested the glucose transporter half-saturation constant (Km) was unchanged by
PTZ, we derived estimates of 1) treated and 2)
control maximal transporter velocities (Vmax)
and 3) a single Km. In cortex, the
glucose transporter Vmax was 42 ± 11% higher (P < 0.05) in PTZ-treated animals
(2.46 ± 0.34 µmol · min
1 · g
1) than in
control animals (1.74 ± 0.26 µmol · min
1 · g
1), and
the Km = 9.5 ± 1.6 mM. Blood-brain
barrier (BBB) Vmax was 31 ± 10%
greater (P < 0.05) in PTZ-treated (2.36 ± 0.30 µmol · min
1 · g
1) than
control subcortex (1.80 ± 0.25 µmol · min
1 · g
1). We
conclude acute upregulation of BBB glucose transport occurs within 3 min of an initial seizure. Transporter Vmax and
BBB glucose permeability increase by 30-40%.
blood-brain barrier glucose transporter; maximal velocity; half-saturation constant; pentylene tetrazole seizures; unsaturated permeability-surface area products; transporter recruitment; intrinsic activity
This article has been cited by other articles:
![]() |
T. P. Obrenovitch Molecular Physiology of Preconditioning-Induced Brain Tolerance to Ischemia Physiol Rev, January 1, 2008; 88(1): 211 - 247. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Blodgett, J. K. De Zutter, K. B. Levine, P. Karim, and A. Carruthers Structural Basis of GLUT1 Inhibition by Cytoplasmic ATP J. Gen. Physiol., July 30, 2007; 130(2): 157 - 168. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Pfund, K. Kagawa, C. Juhasz, Chenggang Shen, Joon Soo Lee, D. C. Chugani, O. Muzik, and H. T. Chugani Quantitative Analysis of Gray- and White-Matter Volumes and Glucose Metabolism in Sturge-Weber Syndrome J Child Neurol, February 1, 2003; 18(2): 119 - 126. [Abstract] [PDF] |
||||
![]() |
G. E. Mann, D. L. Yudilevich, and L. Sobrevia Regulation of Amino Acid and Glucose Transporters in Endothelial and Smooth Muscle Cells Physiol Rev, January 1, 2003; 83(1): 183 - 252. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |